Search
for

    Sort by

    Research 331–360 of 1000+

    1. Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism* The Journal of Clinical Endocrinology and Metabolism · 1997 · 31 citations
    2. Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy Critical Reviews in Therapeutic Drug Carrier Systems · 2017 · 28 citations
    3. Estimating the Contribution of the Prostate to Blood Dihydrotestosterone 2003 · 28 citations
    4. Let astaxanthin be thy medicine PharmaNutrition · 2015 · 27 citations
    5. New drugs under investigation for the treatment of alopecias Expert Opinion on Investigational Drugs · 2019 · 26 citations
    6. Topically Applied Minoxidil in Baldness International Journal of Dermatology · 1985 · 26 citations
    7. Hirsutism Journal of General Internal Medicine · 1995 · 10 citations
    8. Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia Skin appendage disorders · 2020 · 8 citations
    9. Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors Uro · 2021 · 6 citations
    10. Association of Early-onset Androgenetic Alopecia and Metabolic Syndrome JCPSP. Journal of the College of Physicians & Surgeons Pakistan · 2021 · 5 citations
    11. Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia Journal of Complementary and Integrative Medicine · 2009 · 5 citations
    12. The effect of finasteride on spermatogenesis of Mesocricetus auratus Acta Cirurgica Brasileira · 2008 · 5 citations
    13. Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health Current Urology Reports · 2025 · 4 citations
    14. Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement Urology Annals · 2024 · 2 citations
    15. Dermatological drugs, topical agents, and cosmetics Side effects of drugs annual · 2005 · 1 citations
    16. Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies Frontiers in Pharmacology · 2026
    17. Physical Treatments and Therapies for Androgenetic Alopecia Journal of Clinical Medicine · 2024
    18. 4 Platelet-Rich Plasma for Alopecia and Hair Restoration Georg Thieme Verlag eBooks · 2019
    19. Medications Springer eBooks · 2016
    20. Lab Quality Management and Methodology Indian Journal of Medical Biochemistry · 2015
    21. The efficacy and safety of the combination of photobiomodulation therapy and pulsed electromagnetic field therapy on androgenetic alopecia Journal of Cosmetic Dermatology · 2022
    22. The prevalence of androgen excess among patients with minimal unwanted hair growth American Journal of Obstetrics and Gynecology · 2004 · 83 citations
    23. Drinking Frequency but not Years may be Associated with Lower Urinary Tract Symptoms: Result from a Large Cross-Sectional Survey in Chinese Men Risk Management and Healthcare Policy · 2020
    24. Ejaculatory dysfunction in the treatment of lower urinary tract symptoms Translational Andrology and Urology · 2016 · 26 citations
    25. The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy Biomedicines · 2020 · 11 citations
    26. Higher Levels of Serum Uric Acid Have a Significant Association with Lower Incidence of Lower Urinary Tract Symptoms in Healthy Korean Men Metabolites · 2022 · 8 citations
    27. The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection International Journal of Molecular Sciences · 2023 · 8 citations
    28. DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 2004 · 235 citations
    29. Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia Research and Reports in Urology · 2019 · 26 citations
    30. Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome Best Practice & Research in Clinical Obstetrics & Gynaecology · 2004 · 19 citations